Heart insufficiency is frequent and important complication of acute myocardial infarction (AMI). Aim of this work was to estimate frequency, haevyness and course of heart insufficiency in patients with AMI who were different treated in initial phase of AMI, based on what they were separated in three different therapeutic groups: group treated with thrombolytic therapy, group treated with beta-blockers and group treated with nitrates. It was shown that time of admission and condition of patient in moment of admission is the key factor for choise of therapy but using of therapy making less frequency and heavyness of heart insufficiency while for cases with most difficult forms of insufficiency of heart as a pump thrombolytic therapy is practically only posible choice
Montague TJ. Non-Q-wave acute myocardial infarction: body surface potential map and ventriculographic pattern. Am J Cardiol. 58(1173).
2.
Marčetić Z, Vujović D. Terapijski efekti trombolitičke terapije u bolesnika sa akutnim infarktom miokarda komplikovanim teškim srčanim popuštanjem. U zborniku radova I jugoslovenskog kongresa o farmakoterapiji kardiovaskularnih oboljenja.
3.
Terzić B i sar. Primena metoprolola u bolesnika sa akutnim infarktom miokarda i srčanom insuficijencijom. U zborniku radova XI kongresa kardiologa Jugoslavije. 16. (Suppl. 1.
4.
Marčetić Z, Vujović D. Primena beta-blokatora u bolesnika sa akutnim infarktom miokarda komplikovanim početnom srčanom insuficijencijom. U zborniku radova I jugoslovenskog kongresa o farmakoterapiji kardiovaskularnih oboljenja.
5.
Bošković D i sar. Primena metoprolola u akutnom infarktu miokarda sa disfunkcijom leve komore. U zborniku radova: Disfunkcija miokarda leve komore i srčana insuficijencija u koronarnoj bolesti. Niška banja. :387–91.
6.
Chesebro JH, Knatterud G, Roberts R. Thrombolysis in myocardial infarction (TIMI) trial, Phase I: A comparison between intravenous plasminogen activator and intravenous streptokinase. Circulation. 76:142–54.
7.
Braunwald E. Heart disease, a textbook of cardiovascular medicine.
8.
Stamm RB. Echocardiographic detection of infarct-localized asynergy and remote asynergy during acute myocardial infarction: correlation with extent of angiographic coronary disease. Circulation. 67(223).
9.
Picard MH, Wilkins GT, Ray PA, Weyman AE. Natural history of left ventricular size and function after acute myocardial infarction: assessment and prediction by echocardiographic endocardial surface mapping. Circulation. 82(484).
10.
Topol EJ, Ellis SG. Coronary collaterals revisited: Accessory pathway to myocardial preservation during infarction. Circulation. 83:1084–6.
11.
Ward Kennedy I. Streptokinase for the Treatment of Acute Myocardial Infarction: A Brief Review of Randomized Trials. Am J Cardiol. 5.
12.
13.
The ISIS-2 Collaborative Group. Randomized trial of intravenous streptokinase, oral aspirin, both, or neither among 17,187 cases of suspected acute myocardial infarction: ISIS-2. 2:349–60.
14.
Ćirić S, Ćirić V, Đorđević B, Lazović M, Radosavljević M. Trombolitička terapija akutnog infarkta miokarda u prevenciji srčane insuficijencije. U zborniku radova: Disfunkcija miokarda leve komore i srčana insuficijencija u koronarnoj bolesti. Niška banja. :476–8.
15.
Investigators TGUSTO. An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. N Engl J Med. 329:673–82.
16.
Gruppo Italiano per lo Studio della Streptochinasi nell’Infarto Miocardico (GISSI). Long-term effects of intravenous thrombolysis in acute myocardial infarction: final report of the GISSI study. Lancet. 2:871–4.
17.
Braunwald E. The open-artery theory is alive and well again. N Engl J Med. 329:1650–2.
18.
Vasiljević Z, Mitrović P. Ishemijska miokardiopatija. Vol. 19. (br.3):80-84.
19.
20.
Ćirić V. Srčana insuficijencija u akutnom infarktu miokarda. Doktorska disertacija, Medicinski fakultet Univerziteta u Nišu.
21.
Lown P, Wolf M. Aproaches to sudden death from coronary heart disease. Circulation. 44:143–51.
22.
Đorđević BS. Značaj pojave aritmija u akutnom infarktu miokarda i fiziopatija poremećaja ritma. In: U zborniku radova: Poremećaji srčanog ritma, Niška banja. p. 201–6.
23.
Ćirić V, Ćirić S, Benedeto L, Ignjatović R, Glasnović J, Nikolić P, et al. Srčana insuficijencija u akutnom infarktu miokarda. U zborniku radova: Disfunkcija miokarda leve komore i srčana insuficijencija u koronarnoj bolesti. Niška banja. :479–82.
24.
Ostojić M, Nedeljković S, Kanjuh V, Vuzevski V. Interventne kardiološke metode u lečenju ishemijske bolesti srca.
25.
DeWood MA. Prevalence of total coronary occlusion during the early hours of transmural myocardial infarction. N Engl J Med. 303:897–902.
26.
DeWood MA. The relationship of Coronary Thrombosis to Ischemic Myocardial Necrosis. In: Thrombolysis in Cardiovascular Disease.
27.
DeWood MA, Spores J. Coronary arteriographic findings in acute transmural myocardial infarction. Circulation. :68.
28.
Stožinić S, Lambić I, Babić M. Akutni koronarni sindromi.
29.
Simoons ML. Early thrombolysis in acute myocardial infarction: limitation of infarct size and improved survival. Am J Coll Cardiol. 7:717–28.
30.
The ISAM Study Group A prospective trial of intravenous streptokinase in acute myocardial infarction. N Engl J Med. 314:1465–71.
31.
Schiller N, Shah PM, Crawford M. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echo. 2:358–68.
32.
Vasiljević Z. Remodelovanje leve komore posle akutnog infarkta miokarda - mesto ACE-inhibitora. ICN Galenika za medicinu, farmaciju i stomatologiju. Vol. br.7):52-58.
33.
Reimer KA, Kowe JE, Rasmunssen MM, Jennings RB. The wavefront phenomenon of ischaemic cell death. Circulation. 56:786–94.
34.
Constantini C, Cordey E, Lang TW. Revascularization after 3 hours of coronary artery occlusion: Effects on regional cardial metabolic function and infarct size. Am J Cardiol. 36(368).
35.
Rentrop KP. Late thrombolytic therapy preserves left ventricular function in patients with collateralized total coronary occlusion: primary end point of the Second Mount Sinai New York University Reperfusion Trial. J Am Coll Cardiol. 14:58–64.
The statements, opinions and data contained in the journal are solely those of the individual authors and contributors and not of the publisher and the editor(s). We stay neutral with regard to jurisdictional claims in published maps and institutional affiliations.
